- Home
- SNGX vs AREB Comparison
SNGX vs AREB Comparison
Compare SNGX & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- AREB
- Stock Information
- Founded
- SNGX 1987
- AREB 2014
- Country
- SNGX United States
- AREB United States
- Employees
- SNGX N/A
- AREB N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- AREB Plastic Products
- Sector
- SNGX Health Care
- AREB Industrials
- Exchange
- SNGX Nasdaq
- AREB Nasdaq
- Market Cap
- SNGX 6.5M
- AREB 5.7M
- IPO Year
- SNGX 1987
- AREB N/A
- Fundamental
- Price
- SNGX $1.93
- AREB $1.69
- Analyst Decision
- SNGX
- AREB
- Analyst Count
- SNGX 0
- AREB 0
- Target Price
- SNGX N/A
- AREB N/A
- AVG Volume (30 Days)
- SNGX 18.1K
- AREB 1.5M
- Earning Date
- SNGX 05-09-2025
- AREB 06-17-2025
- Dividend Yield
- SNGX N/A
- AREB N/A
- EPS Growth
- SNGX N/A
- AREB N/A
- EPS
- SNGX N/A
- AREB N/A
- Revenue
- SNGX $2,342.00
- AREB $9,887,755.00
- Revenue This Year
- SNGX N/A
- AREB N/A
- Revenue Next Year
- SNGX N/A
- AREB N/A
- P/E Ratio
- SNGX N/A
- AREB N/A
- Revenue Growth
- SNGX N/A
- AREB N/A
- 52 Week Low
- SNGX $1.68
- AREB $1.10
- 52 Week High
- SNGX $14.83
- AREB $231.75
- Technical
- Relative Strength Index (RSI)
- SNGX 49.95
- AREB 38.28
- Support Level
- SNGX $1.86
- AREB $1.51
- Resistance Level
- SNGX $1.97
- AREB $1.88
- Average True Range (ATR)
- SNGX 0.09
- AREB 0.23
- MACD
- SNGX 0.01
- AREB 0.13
- Stochastic Oscillator
- SNGX 70.59
- AREB 26.05
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.